Gila Monster Lizard and Incretin-mimetics
Dhungat, J.P.
Journal of the Association of Physicians of India 65(4): 96
2017
ISSN/ISBN: 0004-5772 PMID: 28527176 Document Number: 693427
Document emailed within 1 workday
Related Documents
Scheen, A.J.; Radermecker, R.P.; Philips, J.C.; Paquot, N. 2007: Incretin mimetics and incretin enhancers for the treatment of type 2 diabetes Revue Medicale Suisse 3(122): 1884; 1886-1888Stahnke, H.L.; Heffron, W.A.; Lewis, D.L. 1970: Bite of the Gila monster Rocky Mountain Medical Journal 67(9): 25-30
Harada, N.; Inagaki, N. 2010: Incretin and incretin-based therapies Nihon Rinsho. Japanese Journal of Clinical Medicine 68(5): 931-942
Campbell, R.K.; Cobble, M.E.; Reid, T.S.; Shomali, M.E. 2010: Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies Journal of Family Practice 59(9 Suppl 1: S20-S27
Godfrey-Faussett, P.; Baggaley, R.; Scott, G.; Sichone, M. 1994: HIV in Zambia: myth or monster? Nature 368(6468): 183-184
Clarke, R.L. 1993: Tame the healthcare paperwork monster Healthcare Financial Management: Journal of the Healthcare Financial Management Association 47(4): 12
Stiemerling, D. 1973: Analysis of a spider and monster phobia Zeitschrift für Psychosomatische Medizin und Psychoanalyse 19(4): 327-345
Valentini, D. 1985: A case of a double di-cephaleous monster Pathologica 77(1048): 189-197
Camps Cervantes, A.; López Gil, V.; Miranda Pitchot, L.; Puigdollers Colás, F. 1985: Beta-mimetics in obstetrics Revista Espanola de Anestesiologia y Reanimacion 32(5): 242-248
Resl, M. 1984: Post-irradiation monster cells in the testes of dogs Ceskoslovenska Patologie 20(4): 241-245
Nikolov, V.; Shtereva, K.; Rachev, E.; Simeonova, E.; Maĭnkhard, K. 1996: A case of a symmetrically conjoined monster in a twin pregnancy Akusherstvo i Ginekologiia 35(1-2): 61-63
Vĕtr, M.; Kudela, M. 1993: Adverse effects of beta-mimetics in obstetrics Ceskoslovenska Gynekologie 58(4): 188-189
Macků, F.; Kronus, R.; Zemenová, M. 1973: Clinical evaluation of beta-mimetics in the prevention of premature labour Ceskoslovenska Gynekologie 38(9): 663-664
Hada, Y.; Yamauchi, T.; Kadowaki, T. 2010: Incretin related drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1900-1905
Freeman, J.S.; Unger, J. 2008: Why and when to implement incretin therapy Journal of Family Practice 57(9 Suppl): S19-S25
Schonauer, S.; Racanelli, A.; D'Addario, V.; Volpe, G. 1977: Morphological changes in placental thermograms. Effect of beta-mimetics (ritodrine hydrochloride) Minerva Ginecologica 29(10): 755-760
Thomazo, E. 2001: An asthmatic patient with concomitant heart disease. can beta mimetics be administered? MMW Fortschritte der Medizin 143(21): 16
Shibasaki, T.; Seino, S. 2011: Regulatory mechanism of incretin secretion Nihon Rinsho. Japanese Journal of Clinical Medicine 69(5): 803-807
Unger, J. 2010: Choosing among the incretin agents and why it matters Journal of Family Practice 59(5 Suppl): S30-S35
Sinzinger, H.; Virgolini, I.; O'Grady, J. 1989: Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease Progress in Clinical and Biological Research 301: 85-96